Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-05-03 @ 5:34 PM
Study NCT ID:
NCT04455594
Status:
UNKNOWN
Last Update Posted:
2020-07-02
First Post:
2020-06-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC
Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HS-LK-2020-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None